Showing results (601-610 of 826) with videos related to

Sort By:
Pageof 83
Pharmacological Reviews|May 2, 2024
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and FutureWei Wang, Najah Albadari, Yi Du, et al.
Pharmacological Reviews|June 16, 2026
Reharnessing the therapeutic potential of gallium-based compounds in oncology: From the laboratory to the clinicChristopher R Chitambar, Casey J Zoss, Mona M Al-Gizawiy, et al.
Pharmacological Reviews|July 20, 2026
Renal aging and associated diseases: Common mechanisms and therapeutic approachesJabir Aliyu Muhammad, Nadya Marcelina Julianto, Tania Setiawan, et al.
Pharmacological Reviews|September 25, 2026
GPCR signaling from a primary cilium perspectiveOlof Idevall-Hagren, Jing Hughes
Pharmacological Reviews|October 8, 2026
Medication adherence: An overlooked critical determinant of pharmacological effectivenessMichel Burnier, Michel Azizi, Pankaj Gupta, et al.
Pharmacological Reviews|July 19, 2003
Specific targeted therapy of chronic myelogenous leukemia with imatinibMichael W N Deininger, Brian J Druker
Pharmacological Reviews|March 5, 2003
International Union of Pharmacology. XXXV. The glucagon receptor familyKelly E Mayo, Laurence J Miller, Dominique Bataille, et al.
Pharmacological Reviews|January 14, 2011
Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissuesMarcela Julio-Pieper, Peter J Flor, Timothy G Dinan, et al.
Pharmacological Reviews|January 20, 2011
Therapeutic targeting of B cells for rheumatic autoimmune diseasesPablo Engel, José A Gómez-Puerta, Manuel Ramos-Casals, et al.
Pharmacological Reviews|November 17, 2010
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂R G Pertwee, A C Howlett, M E Abood, et al.
Pageof 83